Kliniske studier inkluderede 5 patienter i alderen 12- 15 år, de resterende patienter fik voriconazol i specielle kliniske programmer (” compassionate use ”).
Therapeutic studies included 5 patients aged 12-15 years, the remaining patients received voriconazole in the compassionate use programmes.